A novel cereblon modulator for targeted protein degradation-Reference-Cited by-同舟云学术

A novel cereblon modulator for targeted protein degradation

Published:2019-03 Issue: Volume:166 Page:65-74
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Kim Sung Ah,Go Ara,Jo Seung-Hyun,Park Sun Jun,Jeon Young Uk,Kim Ji Eun,Lee Heung Kyoung,Park Chi Hoon^ORCID,Lee Chong-Ock,Park Sung Goo,Kim Pilho,Park Byoung Chul,Cho Sung Yun,Kim Sunhong,Ha Jae Du,Kim Jeong-Hoon,Hwang Jong Yeon^ORCID

Funder

National Research Council of Science and Technology

Ministry of Science, ICT, and future planning

KRIBB Initiative Program

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference40 articles.

1. The evolution of thalidomide and its IMiD derivatives as anticancer agents;Bartlett;Nat. Rev. Canc.,2004

2. Thalidomide and congenital abnormalities;Speirs;Lancet,1962

3. Neuropathy after intake of thalidomide (distaval);Fullerton;Br. Med. J.,1961

4. Thalidomide as an emerging immunotherapeutic agent;Marriott;Immunol. Today,1999

5. First thalidomide clinical trial in multiple myeloma: a decade;van Rhee;Blood,2008

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy;Bioorganic & Medicinal Chemistry;2024-10

2. Applications of protein ubiquitylation and deubiquitylation in drug discovery;Journal of Biological Chemistry;2024-05

3. Development and therapeutic potential of GSPT1 molecular glue degraders: A medicinal chemistry perspective;Medicinal Research Reviews;2024-02-05

4. Role of PROTACs in Hematological Malignancies;PROTAC-Mediated Protein Degradation: A Paradigm Shift in Cancer Therapeutics;2024

5. Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs;Journal of Medicinal Chemistry;2023-10-30